Infinity Pharmaceuticals (INFI)
Add to Watchlists Create an AlertInfinity Pharmaceuticals Current Ratio:
17.67 for Dec. 31, 2012Infinity Pharmaceuticals Historical Current Ratio Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 17.67 |
| Sept. 30, 2012 | 10.78 |
| June 30, 2012 | 2.893 |
| March 31, 2012 | 3.848 |
| Dec. 31, 2011 | 4.070 |
| Sept. 30, 2011 | 3.084 |
| June 30, 2011 | 4.013 |
| March 31, 2011 | 4.839 |
| Dec. 31, 2010 | 3.716 |
| Sept. 30, 2010 | 4.084 |
| June 30, 2010 | 8.304 |
| March 31, 2010 | 8.366 |
| Dec. 31, 2009 | 9.406 |
| Sept. 30, 2009 | 9.183 |
| June 30, 2009 | 9.026 |
| March 31, 2009 | 9.998 |
| Dec. 31, 2008 | 8.522 |
| Sept. 30, 2008 | 4.410 |
| June 30, 2008 | 4.938 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Current Ratio
The current ratio measures a company's ability to pay short-term debts and other current liabilities (financial obligations lasting less than one year) by comparing current assets to current liabilities. The ratio illustrates a company's ability to remain solvent.
A current ratio of one means that book value of current assets is exactly the same as book value of current liabilities. In general, investors look for a company with a current ratio of 2:1, meaning current assets twice as large as current liabilities. A current ratio less than one indicates the company might have problems meeting short-term financial obligations. If the ratio is too high, the company may not be efficiently using its current assets or short term financing facilities.
Other similar solvency ratios include :
Cash Ratio - Measures the amount of cash that can be used to pay liabilities (most strict)
Quick Ratio - Measures the amount of cash, short term equivalents, and accounts receivables that can be used to pay liabilities (more lenient than cash ratio, but stricter than current ratio)
Learn More
INFI Current Ratio Benchmarks
| Companies | |
|---|---|
| Ariad Pharmaceuticals | 4.507 |
| Halozyme Therapeutics | 6.916 |
| Synageva BioPharma |
INFI Current Ratio Rankings
| Overall |
97th percentile 205 of 8009 |
| Sector |
96th percentile 22 of 687 in Healthcare |
| Industry |
94th percentile 14 of 248 in Biotechnology |
INFI Current Ratio Range, Past 5 Years
| Minimum | 2.893 | Jun 2012 |
| Maximum | 17.67 | Dec 2012 |
| Average | 6.902 |
